Tandem Diabetes Care Inc. (TNDM) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Tandem Diabetes Care Inc. (TNDM:NASDAQ), powered by AI.

Current Price
$16.69
P/E Ratio
-5.5
Market Cap
1.1B
Sector
Healthcare
What is the Tandem Diabetes Care Inc. stock price forecast?

Tandem Diabetes Care Inc. is currently trading at $16.69. View real-time AI analysis on Alpha Lenz.

What is Tandem Diabetes Care Inc. insider trading activity?

View the latest insider trading data for Tandem Diabetes Care Inc. on Alpha Lenz.

What is Tandem Diabetes Care Inc.'s P/E ratio?

Tandem Diabetes Care Inc.'s P/E ratio is -5.5.

Tandem Diabetes Care Inc.

NASDAQ · TNDM
$16.69-0.07(-0.42%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Tandem Diabetes Care Inc.'s future dividend policy...
Alpha Chat Insight

Tandem Diabetes Care Inc. trades at a P/E of -5.5 (undervalued) with modest ROE of -97.9%.

Ask for details

Company Overview

Tandem Diabetes Care Inc. is a medical device company specializing in the design and manufacturing of innovative insulin delivery systems. The company's primary focus is on products intended for diabetes management, making significant contributions to the healthcare sector. Tandem's flagship product, the t:slim X2 insulin pump, is known for its compact size, user-friendly interface, and advanced features such as Bluetooth connectivity and compatibility with continuous glucose monitoring systems. This technology aids in precise and efficient blood sugar control, enhancing the quality of life for diabetes patients. Tandem Diabetes Care plays a pivotal role in the diabetes care market by providing cutting-edge solutions that cater to an unmet medical need, collaborating with healthcare providers to improve patient outcomes. Established in the United States, Tandem's advancements underline its commitment to leveraging technology to foster better health management, setting industry standards for modern diabetes care.

CEOMr. John F. Sheridan
SectorHealthcare
IndustryMedical Devices
Employees2,650

Company Statistics

FY 2025

Profile

$1.12BMarket Cap
$1.01BRevenue
0.00Shares Out
2,650Employees

Margins

53.81%Gross
-15.43%EBITDA
-16.49%Operating
-19.74%Pre-Tax
-20.17%Net

Valuation

-5.49P/E
7.24P/B
1.11EV/Sales
-9.43EV/EBITDA
-10.37P/FCF

Growth (CAGR)

8.19%Rev 3Yr
15.26%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-22.15%ROA
-97.88%ROE
-21.01%ROIC

Financial Health

$90.63MCash & Cash Equivalents
$635.31MNet Debt
467.84%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Tandem Diabetes Care Inc. (ticker: TNDM) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 2,650 employees. Market cap is $1.1B.

The current price is $16.69 with a P/E ratio of -5.49x and P/B of 7.24x.

ROE is -97.88% and operating margin is -16.49%. Annual revenue is $1.0B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Tandem Diabetes Care Inc. (TNDM) Stock Forecast 2026 $16.69 — Price, Financials & Analyst Targets | Alpha Lenz